The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534 · cited 1×
“Lymph nodes were considered positive if their short axis was >10 mm; anatomic locations were recorded following the international classification [15].”
MethodThe National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735 · cited 1×
“First, WBMRI offers the ability to quantify tumour load and response to therapy not only in soft-tissue metastases, which seldom occur in PCa but more importantly in bone, the most prevalent metastatic site [9,10,29].”
BackgroundEAU Guidelines on Prostate Cancer
Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V. B., Schmid, H. P., & Zattoni, F. (2008) · European Urology · doi:10.1016/j.eururo.2007.09.002 · Cited by 3,136
Scher, H. I., Halabi, S., Tannock, I., Morris, M., Sternberg, C. N., Carducci, M. A., Eisenberger, M. A., Higano, C., Bubley, G. J., Dreicer, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4487 · Cited by 2,241
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Freedland, S. J., Humphreys, E. B., Mangold, L. A., Eisenberger, M., Dorey, F. J., Walsh, P. C., & Partin, A. W. (2005) · JAMA · doi:10.1001/jama.294.4.433 · Cited by 1,358
Hövels, A. M., Heesakkers, R. A. M., Adang, E. M., Jager, G. J., Strum, S., Hoogeveen, Y. L., Severens, J. L., & Barentsz, J. O. (2008) · Clinical Radiology · doi:10.1016/j.crad.2007.05.022 · Cited by 954
Even‐Sapir, E., Metser, U., Mishani, E., Lievshitz, G., Lerman, H., & Leibovitch, I. (2006) · PubMed · Cited by 795
Takahara, T., Imai, Y., Yamashita, T., Yasuda, S., Nasu, S., & CAUTEREN, M. V. (2004) · PubMed · Cited by 781
Dickinson, L., Ahmed, H. U., Allen, C., Barentsz, J. O., Carey, B., Futterer, J. J., Heijmink, S. W., Hoskin, P. J., Kirkham, A., Padhani, A. R., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.12.009 · Cited by 737
Self-citationThe 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer
Mohler, J. L. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0010 · Cited by 614
Smith, M. R., Kabbinavar, F., Saad, F., Hussain, A., Gittelman, M. C., Bilhartz, D. L., Wynne, C., Murray, R., Zinner, N. R., Schulman, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.529 · Cited by 496
Daldrup-Link, H. E., Franzius, C., Link, T. M., Laukamp, D., Sciuk, J., Jürgens, H., Schober, O., & Rummeny, E. J. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.1.1770229 · Cited by 444
Schirrmeister, H., Guhlmann, A., Elsner, K., Kotzerke, J., Glatting, G., Rentschler, M., Neumaier, B., Träger, H., Nüssle, K., & Reske, S. N. (1999) · PubMed · Cited by 329
Heesakkers, R. A., Hövels, A. M., Jager, G. J., van den Bosch, H. C., Witjes, J. A., Raat, H. P., Severens, J. L., Adang, E. M., van der Kaa, C. H., Fütterer, J. J., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70203-1 · Cited by 307 · cited 1×
“It is expected, however, than in the future, MRI will progressively replace CT, because multiparametric MRI is already the gold standard for imaging the prostate, and awaited iron oxide particles should enhance the detection of enlarged lymph nodes [23,24].”
BackgroundProstate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline
Jadvar, H. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077941 · Cited by 290
Schirrmeister, H., Guhlmann, A., Kotzerke, J., Santjohanser, C., Kühn, T., Kreienberg, R., Messer, P., Nüssle, K., Elsner, K., Glatting, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2381 · Cited by 283
Lecouvet, F. E., Geukens, D., Stainier, A., Jamar, F., Jamart, J., d'Othée, B. J., Therasse, P., Berg, B. V., & Tombal, B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2940 · Cited by 223
Self-citationPractical Aspects of Assessing Tumors Using Clinical Diffusion-weighted Imaging in the Body
KOH, D.-M., TAKAHARA, T., IMAI, Y., & COLLINS, D. J. (2007) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.6.211 · Cited by 211
Briganti, A., Passoni, N., Ferrari, M., Capitanio, U., Suardi, N., Gallina, A., Pozzo, L. F. D., Picchio, M., Di Girolamo, V., Salonia, A., et al. (2010) · European Urology · doi:10.1016/j.eururo.2009.12.023 · Cited by 178
Yi, C. A., Shin, K. M., Lee, K. S., Kim, B.-T., Kim, H., Kwon, O. J., Choi, J. Y., & Chung, M. J. (2008) · Radiology · doi:10.1148/radiol.2482071822 · Cited by 177
Budiharto, T., Joniau, S., Lerut, E., Van den Bergh, L., Mottaghy, F., Deroose, C. M., Oyen, R., Ameye, F., Bogaerts, K., Haustermans, K., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.01.015 · Cited by 158
Giannarini, G., Petralia, G., & Thoeny, H. C. (2011) · European Urology · doi:10.1016/j.eururo.2011.09.019 · Cited by 153
Luboldt, W., Küfer, R., Blumstein, N. M., Toussaint, T. L., Kluge, A., Seemann, M. D., & Luboldt, H. (2008) · Radiology · doi:10.1148/radiol.2492080038 · Cited by 121
Komori, T., Narabayashi, I., Matsumura, K., Matsuki, M., Akagi, H., Ogura, Y., Aga, F., & Adachi, I. (2007) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0010-6 · Cited by 114
TOMBAL, B. F., Rezazadeh, A., Therasse, P., Cangh, P. J. V., Berg, B. V., & Lecouvet, F. E. (2005) · The Prostate · doi:10.1002/pros.20280 · Cited by 87
Self-citationLecouvet, F. E., Simon, M., TOMBAL, B. F., Jamart, J., Berg, B. C. V., & Simoni, P. (2010) · European Radiology · doi:10.1007/s00330-010-1879-3 · Cited by 80
Self-citationAbdominal MRI advances in the detection of liver tumours and characterisation
Low, R. N. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70170-5 · Cited by 79
Héliou, R., Normandeau, L., & Beaudoin, G. (2011) · Radiation Protection Dosimetry · doi:10.1093/rpd/ncr024 · Cited by 30
Cited by
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Brunckhorst, O., Darraugh, J., Eberli, D., De Meerleer, G., De Santis, M., Farolfi, A., et al. (2024) · European Urology · doi:10.1016/j.eururo.2024.03.027 · Cited by 1,246
Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
Gillessen, S., Attard, G., Beer, T. M., Beltran, H., Bossi, A., Bristow, R., Carver, B., Castellano, D., Chung, B. H., Clarke, N., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.06.002 · Cited by 642
Self-citationCurrent use of PSMA–PET in prostate cancer management
Maurer, T., Eiber, M., Schwaiger, M., & Gschwend, J. E. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.26 · Cited by 611
Metadata
- Authors
- Lecouvet, F. E., El Mouedden, J., Collette, L., Coche, E., Danse, E., Jamar, F., Machiels, J.-P., Vande Berg, B., Omoumi, P., & Tombal, B.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 62
- Issue
- 1
- Pages
- 68-75
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2122904975
- Cited by
- 303
- References
- 30
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.